Biosimilar Bridging Study Waivers: Public Health Prerogative Or Trade Secret ‘Taking’?

 
• By Sue Sutter
Chess Kings facing each other as a business concept - merger & partnership, or showdown, corporate takeover, strategy, competition, opposition, confrontation, politics, leadership, challenge, survival
Who will control the board – public health or proprietary information arguments?

More from Biosimilars

More from Biosimilars & Generics